NFE2L2 and head and neck squamous cell carcinoma: Given the smaller size of the available clinical samples, however, prognostic analysis of HNSCC carrying a Nrf2 mutation revealed a significant correlation with poor DFS (~ 10 months) (p < 0.0001 by Log-rank analysis; Fig. 2B, Suppl.